Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Vrieling

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cells|December 11, 2022
Divergent Molecular and Cellular Responses to Low and High-Dose Ionizing RadiationBharath Sampadi, Sylvia Vermeulen, Branislav Mišovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatmentKishan A T Naipal, Nicole S Verkaik, Najim Ameziane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018
Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasMarthe M de Jonge, Aurélie Auguste, Lise M van Wijk, et al.
Cancer Research|February 13, 2020
Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12Laëtitia Meulemans, Romy L S Mesman, Sandrine M Caputo, et al.
Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.
Archives of Toxicology|July 8, 2020
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methodsAlice Krebs, Barbara M A van Vugt-Lussenburg, Tanja Waldmann, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Cancer Research|March 12, 2017
<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Romy L S Mesman, Catharina Von Nicolai, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cells|December 11, 2022
Divergent Molecular and Cellular Responses to Low and High-Dose Ionizing RadiationBharath Sampadi, Sylvia Vermeulen, Branislav Mišovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatmentKishan A T Naipal, Nicole S Verkaik, Najim Ameziane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018
Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasMarthe M de Jonge, Aurélie Auguste, Lise M van Wijk, et al.
Cancer Research|February 13, 2020
Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12Laëtitia Meulemans, Romy L S Mesman, Sandrine M Caputo, et al.
Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.
Archives of Toxicology|July 8, 2020
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methodsAlice Krebs, Barbara M A van Vugt-Lussenburg, Tanja Waldmann, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Cancer Research|March 12, 2017
<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Romy L S Mesman, Catharina Von Nicolai, et al.
Pageof 6